<unk>  refers to a regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate<unk> -M) alternating with ifosfamide, etoposide and high-dose cytarabine <unk> , used as a treatment for aggressive forms of non-Hodgkin's lymphoma; also used as primary treatment for AIDS-related and high-risk Burkitt's lymphoma. Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.
CODOX-M/IVAC regimen
ProMACE-CytaBOM regimen
CBV regimen
ProMACE-MOPP regimen
DHAX-R regimen
MVAC regimen
FOLFOX regimen
R-CDOP regimen